Non-alcoholic steatohepatitis is an important growing indication for liver transplantation in Australia and New Zealand

Luis C. Bertot, Gary P. Jeffrey, Luc D. Delriviere, Geoff McCaughan, Michael Crawford, Peter W. Angus, Robert M. Jones, Edward J. Gane, Stephen Munn, Graeme A. Macdonald, Jonathan Fawcett, Alan J. Wigg, John Chen, Leon A. Adams

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)907A-908A
Number of pages2
JournalHepatology
Volume66
Publication statusPublished - Oct 2017
Event68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting - Washington, United States
Duration: 20 Oct 201724 Oct 2017

Cite this

Bertot, L. C., Jeffrey, G. P., Delriviere, L. D., McCaughan, G., Crawford, M., Angus, P. W., Jones, R. M., Gane, E. J., Munn, S., Macdonald, G. A., Fawcett, J., Wigg, A. J., Chen, J., & Adams, L. A. (2017). Non-alcoholic steatohepatitis is an important growing indication for liver transplantation in Australia and New Zealand. Hepatology, 66, 907A-908A.